CAMP4 Therapeutics, a biotechnology company harnessing the power of RNA to restore healthy gene expression, announced that it has raised $45 million to propel the next phase of its scientific strategy, significantly expand its platform and advance multiple preclinical RNA therapies into human testing.
June 15, 2021
· 4 min read